{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:27:46Z","timestamp":1770114466784,"version":"3.49.0"},"reference-count":70,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"22","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cosmet Laser Ther"],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"\n BACKGROUND<\/jats:title>\n Meningiomas represent the most prevalent primary tumors of the central nervous system, with the majority classified as benign (WHO grade I) and exhibiting favorable prognoses. However, a rare subset of meningiomas show malignant behavior, characterized by local invasion and distant metastasis, occurring in less than 1% of cases. Metastatic meningiomas most commonly involve the lungs, bones, liver, and soft tissues, with bone metastases presenting significant diagnostic and therapeutic challenges.<\/jats:p>\n <\/jats:sec>\n \n OBSERVATIONS<\/jats:title>\n A 61-year-old male with a history of recurrent intracranial meningiomas presented with neck pain and digital paresthesia. Imaging studies revealed lesions at the C4 and C5 vertebrae, accompanied by a pathological fracture at C5. Consequently, a C4 and C5 corpectomy with anterior reconstruction was performed. Histomolecular analysis confirmed the presence of an intraosseous anaplastic meningioma.<\/jats:p>\n <\/jats:sec>\n \n LESSONS<\/jats:title>\n Metastatic meningiomas are an uncommon entity that necessitates a multidisciplinary approach for accurate detection and effective management. The integration of molecular and genetic profiling, along with advanced imaging techniques, may facilitate the identification of high-risk tumors, guide personalized treatment strategies, and ultimately improve patient outcomes.<\/jats:p>\n \n https:\/\/thejns.org\/doi\/10.3171\/CASE24863<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/case24863","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:46:15Z","timestamp":1749498375000},"source":"Crossref","is-referenced-by-count":0,"title":["Cervical vertebral metastases from a recurrent intracranial anaplastic meningioma: illustrative case"],"prefix":"10.3171","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4736-4426","authenticated-orcid":true,"given":"Grimi","family":"Alessandro","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"},{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-2286","authenticated-orcid":true,"given":"Mario","family":"De Robertis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"},{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6081-5963","authenticated-orcid":true,"given":"Ali","family":"Baram","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Capo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-863X","authenticated-orcid":true,"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethania","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Pathology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-6451","authenticated-orcid":true,"given":"Marco","family":"Riva","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"},{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pessina","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"},{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Brembilla","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Fornari","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"12","key":"bib1","series-title":"Neuro Oncol","first-page":"iv1","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","unstructured":"Ostrom QTPatil NCioffi GWaite KKruchko CBarnholtz-Sloan JS.CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12suppl 2):iv1-iv96."},{"issue":"10","key":"bib2","series-title":"Neuro Oncol","first-page":"1742","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","unstructured":"Wang JZLandry APRaleigh DRMeningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol. 2024;26(10):1742-1780."},{"issue":"3","key":"bib3","series-title":"J Neurooncol","first-page":"323","article-title":"Distant metastases in meningioma: an underestimated problem","volume":"112","author":"Surov","year":"2013","unstructured":"Surov AGottschling SBolz JDistant metastases in meningioma: an underestimated problem. J Neurooncol. 2013;112(3):323-327."},{"issue":"2","key":"bib4","series-title":"J Neurooncol","first-page":"187","article-title":"A systematic review of extraneural meningioma metastasis: timing, evolution and outlook","volume":"168","author":"Watanabe","year":"2024","unstructured":"Watanabe GYoung KRauber EA systematic review of extraneural meningioma metastasis: timing, evolution and outlook. J Neurooncol. 2024;168(2):187-196."},{"issue":"10","key":"bib5","series-title":"Acta Neurochir (Wien)","first-page":"2873","article-title":"Metastatic meningioma: a case series and systematic review","volume":"165","author":"Himi\u010d","year":"2023","unstructured":"Himi\u010d VBurman RJFountain DMHofer MLivermore LJJeyaretna DS.Metastatic meningioma: a case series and systematic review. Acta Neurochir (Wien). 2023;165(10):2873-2883."},{"issue":"1","key":"bib6","series-title":"Neurooncol Adv","first-page":"vdab084","article-title":"Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation","volume":"3","author":"Vuong","year":"2021","unstructured":"Vuong HGNgo TNMDunn IF.Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation. Neurooncol Adv. 2021;3(1):vdab084."},{"issue":"1","key":"bib7","series-title":"Neurooncol Adv","first-page":"vdac005","article-title":"Clinical trials targeting neurofibromatoses-associated tumors: a systematic review","volume":"4","author":"Souza","year":"2022","unstructured":"Souza GRAbdalla AMahadevan D.Clinical trials targeting neurofibromatoses-associated tumors: a systematic review. Neurooncol Adv. 2022;4(1):vdac005."},{"issue":"3","key":"bib8","series-title":"J Clin Oncol","first-page":"618","article-title":"Alliance A071401: Phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations","volume":"41","author":"Brastianos","year":"2023","unstructured":"Brastianos PKTwohy ELGerstner ERAlliance A071401: Phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations. J Clin Oncol. 2023;41(3):618-628."},{"issue":"5","key":"bib9","series-title":"J Neurosurg","first-page":"1447","article-title":"Meningioma metastases: incidence and proposed screening paradigm","volume":"132","author":"Dalle Ore","year":"2020","unstructured":"Dalle Ore CLMagill STYen AJMeningioma metastases: incidence and proposed screening paradigm. J Neurosurg. 2020;132(5):1447-1455."},{"key":"bib10","series-title":"World Neurosurg","first-page":"593","article-title":"Atypical Intracranial meningioma with metastasis to C7 vertebral body: a case report","volume":"122","author":"Ward","year":"2019","unstructured":"Ward ALRisman ASegar SSharma SVender JR.Atypical Intracranial meningioma with metastasis to C7 vertebral body: a case report. World Neurosurg. Atypi. 2019;122:593-598."},{"issue":"6","key":"bib11","series-title":"Neurol Med Chir (Tokyo)","first-page":"258","article-title":"Malignant intracranial meningioma with spinal metastasis\u2014case report","volume":"49","author":"Kuroda","year":"2009","unstructured":"Kuroda HKashimura HOgasawara KMalignant intracranial meningioma with spinal metastasis\u2014case report. Neurol Med Chir (Tokyo). 2009;49(6):258-261."},{"issue":"6","key":"bib12","series-title":"J Neurosurg Spine","first-page":"775","article-title":"Intracranial meningioma with vertebral or intraspinal metastasis: report of 2 cases and review of the literature","volume":"25","author":"Singh","year":"2016","unstructured":"Singh RRyan CChohan MOTisnado JHadjigeorgiou GFBilsky MH.Intracranial meningioma with vertebral or intraspinal metastasis: report of 2 cases and review of the literature. J Neurosurg Spine. 2016;25(6):775-781."},{"key":"bib13","series-title":"World Neurosurg","first-page":"47","article-title":"Metastatic atypical and anaplastic meningioma: a case series and review of the literature","volume":"101","author":"Kessler","year":"2017","unstructured":"Kessler RAGarzon-Muvdi TYang WMetastatic atypical and anaplastic meningioma: a case series and review of the literature. World Neurosurg. 2017;101:47-56."},{"issue":"2","key":"bib14","series-title":"Jpn J Clin Oncol","first-page":"86","article-title":"Benign metastasizing meningioma","volume":"33","author":"Pramesh","year":"2003","unstructured":"Pramesh CSSaklani APPantvaidya GHBenign metastasizing meningioma. Jpn J Clin Oncol. 2003;33(2):86-88."},{"key":"bib15","series-title":"World Neurosurg","first-page":"274","article-title":"Malignant transformation and spine metastasis of an intracranial Grade I meningioma: in situ immunofluorescence analysis of cancer stem cells case report and literature review","volume":"120","author":"Baeesa","year":"2018","unstructured":"Baeesa SSHussein DAltalhy AMalignant transformation and spine metastasis of an intracranial Grade I meningioma: in situ immunofluorescence analysis of cancer stem cells case report and literature review. World Neurosurg. 2018;120:274-289."},{"key":"bib16","series-title":"World Neurosurg","first-page":"192","article-title":"Metastasis of intracranial meningioma to the osseous spine: systematic literature review and case report","volume":"183","author":"Zhou","year":"2024","unstructured":"Zhou JJFarber SHde Andrada Pereira BMetastasis of intracranial meningioma to the osseous spine: systematic literature review and case report. World Neurosurg. 2024;183:192-203."},{"issue":"4","key":"bib17","series-title":"Acta Radiol Short Rep","first-page":"2047981613494199","article-title":"Vertebral metastases from intracranial meningioma","volume":"3","author":"Zaghouani","year":"2014","unstructured":"Zaghouani HYahyaoui SChabchoub IVertebral metastases from intracranial meningioma. Acta Radiol Short Rep. 2014;3(4):2047981613494199."},{"issue":"1","key":"bib18","series-title":"Cureus","first-page":"e12809","article-title":"Intracranial Grade II meningioma oligometastatic to the cervical spine","volume":"13","author":"Natarajan","year":"2021","unstructured":"Natarajan JMBorn DEHarsh GShuer LMSoltys SG.Intracranial Grade II meningioma oligometastatic to the cervical spine. Cureus. 2021;13(1):e12809."},{"issue":"11","key":"bib19","series-title":"Cureus","first-page":"e11477","article-title":"A Grade I intracranial meningioma with metastasis to multiple vertebral bodies: a case report and literature review","volume":"12","author":"Hanna","year":"2020","unstructured":"Hanna RFeldman AMKeller CESiddiqui MS.A Grade I intracranial meningioma with metastasis to multiple vertebral bodies: a case report and literature review. Cureus. 2020;12(11):e11477."},{"key":"bib20","series-title":"Clin Neurol Neurosurg","first-page":"106995","article-title":"Surgical management of de novo metastatic meningioma of the spine: an underestimated issue for WHO grade II\/III meningiomas","volume":"210","author":"Jia","year":"2021","unstructured":"Jia QWu ZChu RSurgical management of de novo metastatic meningioma of the spine: an underestimated issue for WHO grade II\/III meningiomas. Clin Neurol Neurosurg. 2021;210:106995."},{"issue":"4","key":"bib21","series-title":"J Nucl Med Technol","first-page":"348","article-title":"The complementary role of 68ga-dotatate PET\/CT in diagnosis of recurrent meningioma","volume":"50","author":"Kong","year":"2022","unstructured":"Kong MJYang AFVora SARoss JSYang M.The complementary role of 68ga-dotatate PET\/CT in diagnosis of recurrent meningioma. J Nucl Med Technol. 2022;50(4):348-352."},{"issue":"9","key":"bib22","series-title":"J Nucl Med","first-page":"1409","article-title":"Peptide receptor radionuclide therapy in advanced refractory meningiomas: efficacy and toxicity in a long follow-up","volume":"65","author":"Severi","year":"2024","unstructured":"Severi SGrassi IBongiovanni APeptide receptor radionuclide therapy in advanced refractory meningiomas: efficacy and toxicity in a long follow-up. J Nucl Med. 2024;65(9):1409-1415."},{"issue":"4","key":"bib23","series-title":"Int J Radiat Oncol Biol Phys","first-page":"868","article-title":"68ga-DOTATATE PET: the future of meningioma treatment","volume":"113","author":"Prasad","year":"2022","unstructured":"Prasad RNPerlow HKBovi J68ga-DOTATATE PET: the future of meningioma treatment. Int J Radiat Oncol Biol Phys. 2022;113(4):868-871."},{"issue":"5","key":"bib24","series-title":"Neuro Oncol","first-page":"796","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","unstructured":"Driver JHoffman SETavakol SA molecularly integrated grade for meningioma. Neuro Oncol. 2022;24(5):796-808."},{"issue":"7874","key":"bib25","series-title":"Nature","first-page":"119","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","unstructured":"Nassiri FLiu JPatil VA clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119-125."},{"issue":"12","key":"bib26","series-title":"Nat Med","first-page":"3067","article-title":"Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses","volume":"29","author":"Chen","year":"2023","unstructured":"Chen WCChoudhury AYoungblood MWTargeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med. 2023;29(12):3067-3076."},{"key":"bib27","article-title":"European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection","author":"Sahm","unstructured":"Sahm FBertero LBrandner SEuropean Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection. Neuro Oncol. Published online November 22, 2024. doi:10.1093\/neuonc\/noae253"},{"issue":"3","key":"bib28","series-title":"Hum Genet","first-page":"347","article-title":"Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas","volume":"95","author":"Papi","year":"1995","unstructured":"Papi LDe Vitis LRVitelli FSomatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet. 1995;95(3):347-351."},{"issue":"1","key":"bib29","series-title":"Acta Neuropathol Commun","first-page":"171","article-title":"Distinct genomic subclasses of high-grade\/progressive meningiomas. NF2-associated, NF2-exclusive, and NF2-agnostic","volume":"8","author":"Williams","year":"2020","unstructured":"Williams EASantagata SWakimoto HDistinct genomic subclasses of high-grade\/progressive meningiomas. NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun. 2020;8(1):171."},{"issue":"3","key":"bib30","series-title":"Clin Cancer Res","first-page":"552","article-title":"Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial","volume":"26","author":"Graillon","year":"2020","unstructured":"Graillon TSanson MCampello CEverolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial. Clin Cancer Res. 2020;26(3):552-557."},{"issue":"3","key":"bib31","series-title":"J Neurooncol","first-page":"749","article-title":"Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2","volume":"139","author":"Osorio","year":"2018","unstructured":"Osorio DSHu JMitchell CEffect of lapatinib on meningioma growth in adults with neurofibromatosis type 2. J Neurooncol. 2018;139(3):749-755."},{"issue":"9","key":"bib32","series-title":"Neuro Oncol","first-page":"1163","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis","year":"2012","unstructured":"Karajannis MALegault GHagiwara MPhase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol. 2012;14(9):1163-1170."},{"issue":"5","key":"bib33","series-title":"Neuro Oncol","first-page":"755","article-title":"Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)","volume":"24","author":"Preusser","year":"2022","unstructured":"Preusser MSilvani ALe Rhun ETrabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG). Neuro Oncol. 2022;24(5):755-767."},{"issue":"1","key":"bib34","series-title":"Trials","first-page":"519","article-title":"The ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","unstructured":"Jenkinson MDJavadpour MHaylock BJThe ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial. Trials. 2015;16(1):519."},{"issue":"11","key":"bib35","series-title":"Nat Med","first-page":"3173","article-title":"Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma","volume":"30","author":"Wang","year":"2024","unstructured":"Wang JZPatil VLandry APMolecular classification to refine surgical and radiotherapeutic decision-making in meningioma. Nat Med. 2024;30(11):3173-3183."},{"issue":"12","key":"bib1","series-title":"Neuro Oncol","first-page":"iv1","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","unstructured":"Ostrom QTPatil NCioffi GWaite KKruchko CBarnholtz-Sloan JS.CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12suppl 2):iv1-iv96."},{"issue":"10","key":"bib2","series-title":"Neuro Oncol","first-page":"1742","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","unstructured":"Wang JZLandry APRaleigh DRMeningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol. 2024;26(10):1742-1780."},{"issue":"3","key":"bib3","series-title":"J Neurooncol","first-page":"323","article-title":"Distant metastases in meningioma: an underestimated problem","volume":"112","author":"Surov","year":"2013","unstructured":"Surov AGottschling SBolz JDistant metastases in meningioma: an underestimated problem. J Neurooncol. 2013;112(3):323-327."},{"issue":"2","key":"bib4","series-title":"J Neurooncol","first-page":"187","article-title":"A systematic review of extraneural meningioma metastasis: timing, evolution and outlook","volume":"168","author":"Watanabe","year":"2024","unstructured":"Watanabe GYoung KRauber EA systematic review of extraneural meningioma metastasis: timing, evolution and outlook. J Neurooncol. 2024;168(2):187-196."},{"issue":"10","key":"bib5","series-title":"Acta Neurochir (Wien)","first-page":"2873","article-title":"Metastatic meningioma: a case series and systematic review","volume":"165","author":"Himi\u010d","year":"2023","unstructured":"Himi\u010d VBurman RJFountain DMHofer MLivermore LJJeyaretna DS.Metastatic meningioma: a case series and systematic review. Acta Neurochir (Wien). 2023;165(10):2873-2883."},{"issue":"1","key":"bib6","series-title":"Neurooncol Adv","first-page":"vdab084","article-title":"Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation","volume":"3","author":"Vuong","year":"2021","unstructured":"Vuong HGNgo TNMDunn IF.Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation. Neurooncol Adv. 2021;3(1):vdab084."},{"issue":"1","key":"bib7","series-title":"Neurooncol Adv","first-page":"vdac005","article-title":"Clinical trials targeting neurofibromatoses-associated tumors: a systematic review","volume":"4","author":"Souza","year":"2022","unstructured":"Souza GRAbdalla AMahadevan D.Clinical trials targeting neurofibromatoses-associated tumors: a systematic review. Neurooncol Adv. 2022;4(1):vdac005."},{"issue":"3","key":"bib8","series-title":"J Clin Oncol","first-page":"618","article-title":"Alliance A071401: Phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations","volume":"41","author":"Brastianos","year":"2023","unstructured":"Brastianos PKTwohy ELGerstner ERAlliance A071401: Phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations. J Clin Oncol. 2023;41(3):618-628."},{"issue":"5","key":"bib9","series-title":"J Neurosurg","first-page":"1447","article-title":"Meningioma metastases: incidence and proposed screening paradigm","volume":"132","author":"Dalle Ore","year":"2020","unstructured":"Dalle Ore CLMagill STYen AJMeningioma metastases: incidence and proposed screening paradigm. J Neurosurg. 2020;132(5):1447-1455."},{"key":"bib10","series-title":"World Neurosurg","first-page":"593","article-title":"Atypical Intracranial meningioma with metastasis to C7 vertebral body: a case report","volume":"122","author":"Ward","year":"2019","unstructured":"Ward ALRisman ASegar SSharma SVender JR.Atypical Intracranial meningioma with metastasis to C7 vertebral body: a case report. World Neurosurg. Atypi. 2019;122:593-598."},{"issue":"6","key":"bib11","series-title":"Neurol Med Chir (Tokyo)","first-page":"258","article-title":"Malignant intracranial meningioma with spinal metastasis\u2014case report","volume":"49","author":"Kuroda","year":"2009","unstructured":"Kuroda HKashimura HOgasawara KMalignant intracranial meningioma with spinal metastasis\u2014case report. Neurol Med Chir (Tokyo). 2009;49(6):258-261."},{"issue":"6","key":"bib12","series-title":"J Neurosurg Spine","first-page":"775","article-title":"Intracranial meningioma with vertebral or intraspinal metastasis: report of 2 cases and review of the literature","volume":"25","author":"Singh","year":"2016","unstructured":"Singh RRyan CChohan MOTisnado JHadjigeorgiou GFBilsky MH.Intracranial meningioma with vertebral or intraspinal metastasis: report of 2 cases and review of the literature. J Neurosurg Spine. 2016;25(6):775-781."},{"key":"bib13","series-title":"World Neurosurg","first-page":"47","article-title":"Metastatic atypical and anaplastic meningioma: a case series and review of the literature","volume":"101","author":"Kessler","year":"2017","unstructured":"Kessler RAGarzon-Muvdi TYang WMetastatic atypical and anaplastic meningioma: a case series and review of the literature. World Neurosurg. 2017;101:47-56."},{"issue":"2","key":"bib14","series-title":"Jpn J Clin Oncol","first-page":"86","article-title":"Benign metastasizing meningioma","volume":"33","author":"Pramesh","year":"2003","unstructured":"Pramesh CSSaklani APPantvaidya GHBenign metastasizing meningioma. Jpn J Clin Oncol. 2003;33(2):86-88."},{"key":"bib15","series-title":"World Neurosurg","first-page":"274","article-title":"Malignant transformation and spine metastasis of an intracranial Grade I meningioma: in situ immunofluorescence analysis of cancer stem cells case report and literature review","volume":"120","author":"Baeesa","year":"2018","unstructured":"Baeesa SSHussein DAltalhy AMalignant transformation and spine metastasis of an intracranial Grade I meningioma: in situ immunofluorescence analysis of cancer stem cells case report and literature review. World Neurosurg. 2018;120:274-289."},{"key":"bib16","series-title":"World Neurosurg","first-page":"192","article-title":"Metastasis of intracranial meningioma to the osseous spine: systematic literature review and case report","volume":"183","author":"Zhou","year":"2024","unstructured":"Zhou JJFarber SHde Andrada Pereira BMetastasis of intracranial meningioma to the osseous spine: systematic literature review and case report. World Neurosurg. 2024;183:192-203."},{"issue":"4","key":"bib17","series-title":"Acta Radiol Short Rep","first-page":"2047981613494199","article-title":"Vertebral metastases from intracranial meningioma","volume":"3","author":"Zaghouani","year":"2014","unstructured":"Zaghouani HYahyaoui SChabchoub IVertebral metastases from intracranial meningioma. Acta Radiol Short Rep. 2014;3(4):2047981613494199."},{"issue":"1","key":"bib18","series-title":"Cureus","first-page":"e12809","article-title":"Intracranial Grade II meningioma oligometastatic to the cervical spine","volume":"13","author":"Natarajan","year":"2021","unstructured":"Natarajan JMBorn DEHarsh GShuer LMSoltys SG.Intracranial Grade II meningioma oligometastatic to the cervical spine. Cureus. 2021;13(1):e12809."},{"issue":"11","key":"bib19","series-title":"Cureus","first-page":"e11477","article-title":"A Grade I intracranial meningioma with metastasis to multiple vertebral bodies: a case report and literature review","volume":"12","author":"Hanna","year":"2020","unstructured":"Hanna RFeldman AMKeller CESiddiqui MS.A Grade I intracranial meningioma with metastasis to multiple vertebral bodies: a case report and literature review. Cureus. 2020;12(11):e11477."},{"key":"bib20","series-title":"Clin Neurol Neurosurg","first-page":"106995","article-title":"Surgical management of de novo metastatic meningioma of the spine: an underestimated issue for WHO grade II\/III meningiomas","volume":"210","author":"Jia","year":"2021","unstructured":"Jia QWu ZChu RSurgical management of de novo metastatic meningioma of the spine: an underestimated issue for WHO grade II\/III meningiomas. Clin Neurol Neurosurg. 2021;210:106995."},{"issue":"4","key":"bib21","series-title":"J Nucl Med Technol","first-page":"348","article-title":"The complementary role of 68ga-dotatate PET\/CT in diagnosis of recurrent meningioma","volume":"50","author":"Kong","year":"2022","unstructured":"Kong MJYang AFVora SARoss JSYang M.The complementary role of 68ga-dotatate PET\/CT in diagnosis of recurrent meningioma. J Nucl Med Technol. 2022;50(4):348-352."},{"issue":"9","key":"bib22","series-title":"J Nucl Med","first-page":"1409","article-title":"Peptide receptor radionuclide therapy in advanced refractory meningiomas: efficacy and toxicity in a long follow-up","volume":"65","author":"Severi","year":"2024","unstructured":"Severi SGrassi IBongiovanni APeptide receptor radionuclide therapy in advanced refractory meningiomas: efficacy and toxicity in a long follow-up. J Nucl Med. 2024;65(9):1409-1415."},{"issue":"4","key":"bib23","series-title":"Int J Radiat Oncol Biol Phys","first-page":"868","article-title":"68ga-DOTATATE PET: the future of meningioma treatment","volume":"113","author":"Prasad","year":"2022","unstructured":"Prasad RNPerlow HKBovi J68ga-DOTATATE PET: the future of meningioma treatment. Int J Radiat Oncol Biol Phys. 2022;113(4):868-871."},{"issue":"5","key":"bib24","series-title":"Neuro Oncol","first-page":"796","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","unstructured":"Driver JHoffman SETavakol SA molecularly integrated grade for meningioma. Neuro Oncol. 2022;24(5):796-808."},{"issue":"7874","key":"bib25","series-title":"Nature","first-page":"119","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","unstructured":"Nassiri FLiu JPatil VA clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119-125."},{"issue":"12","key":"bib26","series-title":"Nat Med","first-page":"3067","article-title":"Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses","volume":"29","author":"Chen","year":"2023","unstructured":"Chen WCChoudhury AYoungblood MWTargeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med. 2023;29(12):3067-3076."},{"key":"bib27","article-title":"European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection","author":"Sahm","unstructured":"Sahm FBertero LBrandner SEuropean Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection. Neuro Oncol. Published online November 22, 2024. doi:10.1093\/neuonc\/noae253"},{"issue":"3","key":"bib28","series-title":"Hum Genet","first-page":"347","article-title":"Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas","volume":"95","author":"Papi","year":"1995","unstructured":"Papi LDe Vitis LRVitelli FSomatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet. 1995;95(3):347-351."},{"issue":"1","key":"bib29","series-title":"Acta Neuropathol Commun","first-page":"171","article-title":"Distinct genomic subclasses of high-grade\/progressive meningiomas. NF2-associated, NF2-exclusive, and NF2-agnostic","volume":"8","author":"Williams","year":"2020","unstructured":"Williams EASantagata SWakimoto HDistinct genomic subclasses of high-grade\/progressive meningiomas. NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun. 2020;8(1):171."},{"issue":"3","key":"bib30","series-title":"Clin Cancer Res","first-page":"552","article-title":"Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial","volume":"26","author":"Graillon","year":"2020","unstructured":"Graillon TSanson MCampello CEverolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial. Clin Cancer Res. 2020;26(3):552-557."},{"issue":"3","key":"bib31","series-title":"J Neurooncol","first-page":"749","article-title":"Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2","volume":"139","author":"Osorio","year":"2018","unstructured":"Osorio DSHu JMitchell CEffect of lapatinib on meningioma growth in adults with neurofibromatosis type 2. J Neurooncol. 2018;139(3):749-755."},{"issue":"9","key":"bib32","series-title":"Neuro Oncol","first-page":"1163","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis","year":"2012","unstructured":"Karajannis MALegault GHagiwara MPhase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol. 2012;14(9):1163-1170."},{"issue":"5","key":"bib33","series-title":"Neuro Oncol","first-page":"755","article-title":"Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)","volume":"24","author":"Preusser","year":"2022","unstructured":"Preusser MSilvani ALe Rhun ETrabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG). Neuro Oncol. 2022;24(5):755-767."},{"issue":"1","key":"bib34","series-title":"Trials","first-page":"519","article-title":"The ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","unstructured":"Jenkinson MDJavadpour MHaylock BJThe ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial. Trials. 2015;16(1):519."},{"issue":"11","key":"bib35","series-title":"Nat Med","first-page":"3173","article-title":"Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma","volume":"30","author":"Wang","year":"2024","unstructured":"Wang JZPatil VLandry APMolecular classification to refine surgical and radiotherapeutic decision-making in meningioma. Nat Med. 2024;30(11):3173-3183."}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/9\/22\/article-CASE24863.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/9\/22\/article-CASE24863.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/9\/22\/article-CASE24863.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:37:27Z","timestamp":1770075447000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/9\/22\/article-CASE24863.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":70,"journal-issue":{"issue":"22"},"URL":"https:\/\/doi.org\/10.3171\/case24863","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}